Serious Event

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event

Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
NCT ID: NCT02243293
Term: Anaemia
Organ System: Blood and lymphatic system disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA version 19.0
Notes: None
Study: NCT02243293
Study Brief: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG004 None 0 30 View
EG007 None 0 54 View
EG010 None 1 27 View
EG013 None 0 22 View
EG015 None 0 145 View
EG016 None 0 58 View
EG000 None 0 25 View
EG001 None 0 24 View
EG002 None 0 25 View
EG003 None 0 30 View
EG005 None 0 31 View
EG006 None 0 30 View
EG008 None 0 53 View
EG009 None 0 28 View
EG011 None 0 40 View
EG012 None 0 22 View
EG014 None 0 47 View